Vertex Pharmaceuticals
VRTX
#171
Rank
C$184.16 B
Marketcap
C$727.07
Share price
1.36%
Change (1 day)
25.17%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2026 (TTM): C$7.02 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are C$12.58 Billion. In 2025 the company made an earning of C$6.87 Billion, an increase over its 2024 earnings that were of C$0.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$7.02 B2.22%
2025 C$6.87 B1627.59%
2024 C$0.39 B-93.69%
2023 C$6.30 B3.19%
2022 C$6.11 B53.56%
2021 C$3.97 B-12.06%
2020 C$4.52 B118.45%
2019 C$2.07 B120.64%
2018 C$0.93 B1473.64%
2017 C$59.66 M197.6%
2016 C$20.04 M-102.97%
2015 -C$0.68 Billion-28.46%
2014 -C$0.95 Billion-51.5%
2013 -C$1.95 Billion-30584.68%
2012 C$6.38 M-95.47%
2011 C$0.14 B
2009 -C$0.85 Billion
2007 -C$0.59 Billion83.1%
2006 -C$0.33 Billion59.02%
2005 -C$0.21 Billion3.28%
2004 -C$0.2 Billion-38.16%
2003 -C$0.32 Billion
2000 -C$54.23 Million-20.38%
1999 -C$68.11 Million31.62%
1998 -C$51.75 Million91.05%
1997 -C$27.09 Million-36.24%
1996 -C$42.48 Million12.45%
1995 -C$37.78 Million27.4%
1994 -C$29.65 Million-1833.33%
1993 C$1.71 M-112.12%
1992 -C$14.12 Million175%
1991 -C$5.14 Million-12.2%
1990 -C$5.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$37.35 B 419.60%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$12.39 B 72.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-C$2.79 Billion-138.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.96 B 52.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$16.97 B 136.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-C$71.58 Million-101.00%๐Ÿ‡บ๐Ÿ‡ธ USA